Navigation Links
William Cork Joins Fenwal as Chief Technology Officer
Date:11/10/2009

LAKE ZURICH, Ill., Nov. 10 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today William H. Cork has joined the company as senior vice president and chief technology officer. Mr. Cork, 50, will lead Fenwal's research and development, regulatory and clinical affairs teams, reporting to Ron K. Labrum, Fenwal's president and chief executive officer.

Mr. Cork joins Fenwal from Northbrook, Illinois-based Nanosphere Inc. (Nasdaq: NSPH), where he was chief technology officer and vice president of research and development since 2001. Nanosphere focuses on molecular diagnostic testing.

Prior to this, Mr. Cork was vice president of research and development for Fenwal (then a division of Baxter International), where he led the development and global commercialization of platelet and cell-collection technologies, including Fenwal's Amicus and CS-3000 separator portfolios.

"Bill is a strong and experienced scientific leader, with deep knowledge of advanced molecular science, software development and transfusion medicine with clinical relationships worldwide," Labrum said. "His decade-long tenure with us in the 1990s was one of the most innovative and productive periods in Fenwal's recent history."

Mr. Cork holds more than 15 medical-technology patents and has another seven pending. He earned a bachelor's degree in electrical engineering from Northwestern University, where he also minored in biomedical engineering. Mr. Cork replaces Hiroshi Uchida as a member of Fenwal's executive team. Mr. Uchida transitioned last month to Fenwal's board of directors.

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used throughout the world to help ensure a safe and available supply of lifesaving blood and blood products. Fenwal Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

SOURCE Fenwal Inc.


'/>"/>
SOURCE Fenwal Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
3. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
4. Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
5. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
6. Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks
7. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
8. Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National Active Lifestyle Skincare Destinations
9. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
10. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):